InvestorsHub Logo
Followers 0
Posts 2715
Boards Moderated 0
Alias Born 08/04/2003

Re: Amanita post# 40593

Monday, 07/01/2013 1:01:35 PM

Monday, July 01, 2013 1:01:35 PM

Post# of 45771
I suggest you make mistakes by asking questions about ValiMed on a stock chat board. Your questions and concerns can best be answered by those that work with it directly.

If you would like to know about the earlier version of ValiMed stopping diversion, consider James Jorgenson.

http://www.linkedin.com/pub/jim-jorgenson/11/4a4/427

If you would like to know about the new G4 from someone that is also familiar with S.E.A. Medical, consider Luci A. Power, M.S., B.S.Pharm.

http://www.ashpadvantagemedia.com/downloads/handout_iv-medsafety_mcm.pdf

"ValiMed G4" "Luci A. Power"

New technology allows testing in the I.V. Room
–CDEX - Valimed G4
–SEA Medical – IV Check

http://ashpmedia.org/symposia/lmsvideo/content/iv-medsafety/resources/handout_iv-medsafety_ondemand.pdf

For the 18-month peer reviewed ValiMed Study, consider trying Yaman Kaakeh, Pharm.D. That study is also available via
US National Library of Medicine National Institutes of Health

http://www.ncbi.nlm.nih.gov/pubmed/18159039

CONCLUSION:

A tabletop EPS device demonstrated acceptable sensitivity and specificity for validating the identity and concentrations of selected high-risk i.v. medications compounded for pediatric patients. The device may help prevent clinically important medication errors caused by inaccurate compounding.

PMID: 18159039 [PubMed - indexed for MEDLINE]

....
Dr Kaakeh

http://www.purdue.edu/newsroom/faculty/2010/100115Notebook.html

Her winning article, “Enhanced Photoemission Spectroscopy for Verification of High-Risk I.V. Medications,” was co-authored with Hanna Phan, Pharm.D., Brian D. DeSmet, Pharm.D., M.S., Deborah A. Pasko, Pharm.D., Denise K. Glenn, B.S.Pharm., and James G. Stevenson, Pharm.D., FASHP. The article was published in the American Journal of Health-System Pharmacy.
....

To contact the company, ask for a visit... (I would strongly suggest asking when and where the ValiMed G4 is being demonstrated the remaining portion of this year, or consider visiting their location).

http://cdex-inc.com/contact/

Office :
4555 S. Palo Verde Road
Suite 123
Tucson, AZ 85714
Phone : 888-701-CDEX (2339)

Email : info@cdex-inc.com



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.